Important note: Information in this article was accurate in 2005. The state of the art may have changed since the publication date.
Integrated Regional Information Networks - December 6, 2005
ABUJA, 6 December (PLUSNEWS) - Anxiety is mounting in Nigeria's HIV/AIDS community amid reports that the Global Fund secretariat has recommended to its board not to extend funding of Nigeria's grant into phase II.
Nigeria's Treatment Action Movement (TAM) described the development as a "big shame" for the country where "the need for HIV treatment scale up is so acute".
The Chairman of the National Action Committee on AIDS (NACA) Professor Babatunde Osotimehin said the country was awaiting the formal decision by the board when it meets in two weeks time.
"The Global Fund raised some issues on the slowness of the implementation of our programmes and our planning and we have responded to those issues. We are not aware of any decision yet," Osotimehin stated.
TAM activists led by Rolake Odetoyinbo declared a vote of no-confidence in the Country's Coordinating Mechanism (CCM), which it accused of not performing its oversight function of NACA - the principal recipient of Global Fund money.
They urged President Olusegun Obasanjo to take immediate action to salvage the possible cancellation of the grant by restructuring the CCM and NACA.
"We cannot afford to loose this important grant due to the inefficiency of the members of the CCM, many of whom do not have the mandate of the groups they are supposed to be representing," Odetoyinbo alleged
Nigeria's first round grant was awarded in 2003. Under Global Fund rules, a decision to fund the last three years of the five-year grant are conditional on meeting key performance targets.
Funding for the first two years totaled US $26.4 million to cover Nigeria's national antiretroviral treatment scheme, and the expansion of its mother-to-child transmission programme. As of October, only US $6 million had been spent. The full five-year grant covering both programmes is worth US $107 million.
051206
IR051223
Copyright © 2005 - Integrated Regional Information Networks (IRIN). Reproduction of this article (other than one copy for personal reference) must be cleared through the Integrated Regional Information Network. .
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980 – 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .